Reuters Health Report

Click to View in Browser 12/17/2013 GSK to stop paying doctors in major marketing overhaul LONDON (Reuters) - GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff - a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit. FDA warns attention deficit drugs may cause long erections (Reuters) - A leading type of stimulant used to treat attention deficit disorder can cause rare cases of painful and long-lasting erections, the U.S. Food and Drug Administration warned on Tuesday. Exclusive: Syria region where polio found excluded from 2012 vaccination drive BEIRUT (Reuters) - The Syrian government excluded the largely rebel-held province of Deir al-Zor - where polio broke out this year - from a 2012 vaccination campaign, arguing that most residents had fled although hundreds of thousands were still there, a Reuters investigation shows. EU issues warning on potential health risk from insecticides LONDON (Reuters) - European health authorities warned on Tuesday that two insecticides, including a widely-used one made by Bayer, may affect the developing human brain and should be more tightly controlled to limit human exposure. Shanghai Pharma opens bribery probe after whistleblower report SHANGHAI (Reuters) - Chinese drugmaker Shanghai Pharmaceuticals Holding Co Ltd said it is investigating an allegation in local media that a subsidiary bribed hospital and industry staff to boost drug sales. Boehringer's blood clot drug shows promise in broader use trial (Reuters) - German drugmaker Boehringer Ingelheim said its popular drug to prevent blood clots was found to be as effective as the standard blood thinner in a trial for broader use. Chr Hansen sees interest in bacteria to reduce infant mortality COPENHAGEN (Reuters) - Danish food ingredients maker Chr. Hansen is in discussions with companies over using probiotic bacteria to reduce the risk of a deadly stomach disease among premature babies. EU agency due to give verdict on Teva MS pill this week LONDON (Reuters) - European regulators are due to decide this week whether or not to recommend approval of a new multiple sclerosis pill from Teva Pharmaceutical Industries, according to a document published on Tuesday. E-cigarette row could block new EU tobacco rules: diplomats BRUSSELS (Reuters) - Disagreement over how to regulate the booming market for electronic cigarettes is holding up a deal on strict new rules governing tobacco products in the European Union, diplomats said on Monday. U.S. to spend $14 million on concussion research, using NFL funds (Reuters) - U.S. researchers on Monday unveiled a $14 million series of research projects aimed at diagnosing and treating brain injuries in football players and others who have suffered multiple head injuries or concussions. Related Video Sea Shepherd ships prepare for departure Snow blasts U.S. Northeast The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend